Summary: Cigna Healthcare modified its Vitamin D Testing coverage policy (policy 0526), effective April 13, 2026. Here's what changes for billing teams.
Cigna Healthcare updated its Vitamin D testing coverage policy — internally tracked as coverage position criteria 0526 — with a modification effective April 13, 2026. This policy governs when Vitamin D testing is covered as medically necessary versus when claims will be denied as not medically indicated. The published policy document does not list specific CPT or HCPCS codes in the data available at publication time. If you bill Vitamin D assays for Cigna members, audit your current claims workflow before April 13, 2026.
| Field | Detail |
|---|---|
| Payer | Cigna Healthcare |
| Policy | Vitamin D Testing – Coverage Position Criteria (0526) |
| Policy Code | 0526 |
| Change Type | Modified |
| Effective Date | April 13, 2026 |
| Impact Level | Medium-High |
| Specialties Affected | Primary care, endocrinology, nephrology, rheumatology, obstetrics, internal medicine |
| Key Action | Review Vitamin D testing orders against updated medical necessity criteria before April 13, 2026 |
Cigna Vitamin D Testing Coverage Criteria and Medical Necessity Requirements 2026
The Cigna Vitamin D testing coverage policy has been a moving target for years. That's not a surprise — Vitamin D testing is one of the most over-ordered labs in primary care, and payers know it.
Cigna's 0526 policy defines when 25-hydroxyvitamin D testing qualifies as medically necessary versus when it's considered routine screening with no covered indication. The core distinction Cigna draws is between diagnostic testing for a symptomatic or at-risk patient and population-level wellness screening ordered without a specific clinical trigger.
The policy document available at the time of publication does not include specific CPT or HCPCS codes in the data provided. However, based on standard Vitamin D testing billing guidelines and Cigna's established position on this service, the relevant codes your team should track include 25-hydroxyvitamin D assays and, in some clinical contexts, 1,25-dihydroxyvitamin D testing. Check the full policy at the Cigna coverage position criteria page for 0526 to confirm which codes are listed in the current revision.
What Cigna Considers Medically Necessary
Cigna's established position on Vitamin D testing ties coverage to specific clinical conditions where Vitamin D deficiency is a recognized risk or complication. These typically include:
| # | Covered Indication |
|---|---|
| 1 | Malabsorption syndromes — Crohn's disease, celiac disease, and post-bariatric surgery patients, where Vitamin D absorption is physiologically compromised |
| 2 | Chronic kidney disease — because renal hydroxylation of Vitamin D is impaired, making monitoring clinically relevant |
| 3 | Osteoporosis or metabolic bone disease — where Vitamin D status directly informs treatment decisions |
| 4 | Conditions requiring systemic corticosteroid use — long-term steroid therapy depletes Vitamin D over time |
| 5 | Documented Vitamin D deficiency on prior testing — follow-up testing to monitor treatment response |
The medical necessity bar is specific. A patient with vague fatigue or a provider who routinely tests Vitamin D on annual physicals doesn't meet Cigna's criteria. That's where most claim denials originate — providers ordering the test without documentation linking it to a covered indication.
Prior Authorization and Reimbursement Considerations
The 0526 policy does not appear to require prior authorization for Vitamin D testing in covered indications — this is a claim-level medical necessity determination, not a prior auth workflow. That said, the absence of prior authorization doesn't mean automatic reimbursement. Cigna reviews Vitamin D claims on the back end.
If your documentation doesn't clearly connect the order to a covered diagnosis, expect a claim denial. The ICD-10 diagnosis code on the claim needs to support the indication — a Z-code for routine exam won't carry a Vitamin D test through adjudication.
Cigna Vitamin D Testing Exclusions and Non-Covered Indications
Cigna has consistently treated population-level Vitamin D screening as not medically necessary. This is the most common reason billing teams see denials on these claims.
General wellness screening — testing ordered as part of a routine annual physical without a specific documented indication — falls outside the coverage policy. Cigna's position here is consistent with the U.S. Preventive Services Task Force (USPSTF), which has not recommended routine Vitamin D screening in healthy adults.
Repeat testing without documented clinical need is another common denial trigger. If a patient tested normal six months ago and nothing has changed clinically, a repeat order won't meet medical necessity criteria. Your documentation needs to show why the repeat test is warranted — a new medication, a change in condition, or treatment monitoring for a documented deficiency.
Testing in pediatric wellness visits without a specific at-risk indication is another area where Cigna draws a hard line. Not all pediatric Vitamin D testing is excluded, but routine testing without a documented clinical reason won't be covered.
Coverage Indications at a Glance
The specific coverage indicators listed below are based on Cigna's established 0526 policy position and standard industry criteria for Vitamin D testing medical necessity. The April 13, 2026 modification may have adjusted the language, criteria weighting, or added new indications — confirm the current version at the official policy source before the effective date.
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Malabsorption syndromes (Crohn's, celiac, bariatric surgery) | Covered | Confirm with 0526 policy | Document underlying condition clearly |
| Chronic kidney disease | Covered | Confirm with 0526 policy | Stage matters — document CKD stage |
| Osteoporosis / metabolic bone disease | Covered | Confirm with 0526 policy | Link test to treatment decision in notes |
| Long-term corticosteroid therapy | Covered | Confirm with 0526 policy | Duration and dose should be documented |
| Documented prior Vitamin D deficiency (monitoring) | Covered | Confirm with 0526 policy | Must show prior deficiency result |
| Routine annual wellness screening (no specific indication) | Not Covered | N/A | Most common denial trigger |
| Repeat testing without clinical change | Not Covered | N/A | Document clinical rationale for repeats |
| Pediatric well-child visits without at-risk indication | Not Covered | N/A | At-risk populations may qualify |
| Fatigue or non-specific symptoms only | Not Covered | N/A | Symptom alone doesn't meet criteria |
Cigna Vitamin D Testing Billing Guidelines and Action Items 2026
This is where the rubber meets the road. The modification to 0526 is live April 13, 2026. Here's what your billing team needs to do now.
| # | Action Item |
|---|---|
| 1 | Pull your Cigna Vitamin D claim volume from the last 90 days. Identify which providers are ordering these tests and what ICD-10 codes are attached. If you're seeing Z-codes or non-specific diagnosis codes driving Vitamin D orders, that's your denial risk in plain view. |
| 2 | Read the full revised 0526 policy before April 13, 2026. The source document is at Cigna's coverage position criteria page for 0526. The policy data available at publication doesn't include a line-by-line diff of what changed — you need to compare the current version to the prior version yourself or use a policy tracking tool that surfaces the diff automatically. |
| 3 | Update your encounter documentation templates. Work with your clinical informatics or EHR team to add a Vitamin D testing prompt that requires providers to select a covered indication before the order is placed. This is a front-end fix that prevents back-end denials. |
| 4 | Audit ICD-10 code selection for Vitamin D claims. The diagnosis code on the claim is the first thing Cigna's adjudication system checks against the coverage policy. Codes that signal a covered indication — CKD, malabsorption disorders, metabolic bone disease — need to be present and accurate. If you're billing Vitamin D testing and your primary diagnosis is a Z-code, the claim is at risk. |
| 5 | Review denial rates on Vitamin D testing going back six months. If you already have elevated denial rates on these claims, the April 13, 2026 modification may change the specific criteria that are causing them — for better or worse. Know your baseline before the effective date so you can measure the impact of this change. |
| 6 | Brief your ordering providers on the updated criteria. Vitamin D testing billing guidelines only work if the ordering provider documents the right clinical rationale. A two-page clinical summary of what Cigna covers — and what it doesn't — sent to high-volume orderers before April 13, 2026 is worth more than any back-end billing fix. |
| 7 | If your practice sees a high volume of Cigna patients across endocrinology, nephrology, or rheumatology, loop in your compliance officer before the effective date. These specialties have the most legitimate medical necessity scenarios for Vitamin D testing, but they also generate the highest claim volume — which means the most exposure if documentation isn't tight. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Vitamin D Testing Under Cigna Policy 0526
The policy data provided for this modification does not include specific CPT, HCPCS, or ICD-10 codes. Cigna's published policy document for 0526 should list the applicable codes — access the full policy at app.payerpolicy.org/p/cigna/mm_0526_coveragepositioncriteria_vitamin_d_testing. to confirm the exact code set covered under the revised criteria.
Do not assume codes from prior versions of the policy carry forward unchanged. The April 13, 2026 modification may have added, removed, or reclassified specific assay codes. Your Vitamin D testing billing workflow should be validated against the current code list in the revised policy.
What to Look for in the Full Policy Document
When you pull the 0526 policy, look specifically for:
- 25-hydroxyvitamin D assay codes — these are the standard clinical test for deficiency screening and monitoring
- 1,25-dihydroxyvitamin D (calcitriol) assay codes — typically covered in narrower circumstances, often tied to CKD or specific metabolic conditions
- Any new ICD-10-CM diagnosis codes added or removed from the covered indication list
- Any frequency limitations — Cigna sometimes restricts how often a covered test can be billed within a rolling period
If you find codes in the published policy that weren't in the prior version, update your charge capture accordingly before April 13, 2026.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.